Beijing Tongrentang Co., Ltd (600085.SS)

CNY 41.49

(3.73%)

Market Cap (In CNY)

56.9 Billion

Revenue (In CNY)

17.86 Billion

Net Income (In CNY)

1.66 Billion

Avg. Volume

9.33 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
30.84-55.74
PE
-
EPS
-
Beta Value
0.292
ISIN
CNE000000R69
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Chaohua Zhang
Employee Count
-
Website
https://www.tongrentanggf.com
Ipo Date
1997-06-25
Details
Beijing Tongrentang Co., Ltd engages in the scientific research, production, sale, and distribution of Chinese medicines in China and internationally. It covers product formulations, such as pills, powders, wines and capsules, oral liquids, and dripping pills with the original powder preparation in the areas of cardiovascular, cerebrovascular, and gynecological diseases, as well as anti-depressive new drugs. The company sells its products under the brand names of Angong Niuhuang series, Tongren Niuhuang Qingxin series, Tongren Dahuoluo series, Yufeng Ningxin dripping pills, Hemiplegia recovery pills, etc. The company is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.